Tag: <span>Basal cell carcinoma</span>

Home / Basal cell carcinoma
Post

First-in-class histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma

by  American Association for Cancer Research Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation showed signs of clinical efficacy in patients with basal cell carcinoma, according to results from a phase II clinical trial published in Clinical Cancer Research. Basal cell carcinoma (BCC) is the most common form of skin cancer and is typically treated...

Post

Topical skin cream for treatment of basal cell carcinoma shows promise as an alternative to surgery — ScienceDaily

Basal cell carcinoma (BCC), a type of skin cancer, is the most common form of human cancer. With a growing aging population, BCC rates are climbing at an alarming rate, with reported cases rising by as much as 10% per year. Rising demand makes a simple and effective treatment for BCC appealing to both practitioners...